KCM
PDSB icon

Kennedy Capital Management’s PDS Biotechnology PDSB Stock Holding History

Kennedy Capital Management’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,443
Closed -$52.7K – 709
2023
Q3 		$52.7K Buy
10,443
+245
+2% +$1.34K ﹤0.01% 669
2023
Q2 		$51.3K Buy
+10,198
New +$66.8K ﹤0.01% 664

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kennedy Capital Management's PDSB Position: Q4 2023 in Review

Kennedy Capital Management sold out of PDS Biotechnology (PDSB) in Q4 2023, closing a stake of 10,443 shares — an estimated $52.7K sold.

Kennedy Capital Management first reported a position in PDSB in Q2 2023 and held it in 2 quarters. The position peaked at $52.7K in Q3 2023. 77 funds tracked by Wall St. Rank hold PDSB as of Q4 2023.

  • Kennedy Capital Management reported no remaining PDS Biotechnology position as of Q4 2023 after selling out during the quarter.
  • Kennedy Capital Management sold 10,443 PDS Biotechnology shares in Q4 2023, an estimated $52.7K.
  • Kennedy Capital Management first reported a position in PDS Biotechnology in Q2 2023 and held it in 2 quarters.
  • Kennedy Capital Management's PDS Biotechnology position peaked at $52.7K in Q3 2023.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2023.

Based on Kennedy Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.